0001803599-21-000194.txt : 20211103
0001803599-21-000194.hdr.sgml : 20211103
20211103181116
ACCESSION NUMBER: 0001803599-21-000194
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211101
FILED AS OF DATE: 20211103
DATE AS OF CHANGE: 20211103
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: POLK DENNIS
CENTRAL INDEX KEY: 0001270710
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39494
FILM NUMBER: 211376988
MAIL ADDRESS:
STREET 1: 44201 NOBEL DRIVE
CITY: FREMONT
STATE: CA
ZIP: 94538
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Concentrix Corp
CENTRAL INDEX KEY: 0001803599
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-BUSINESS SERVICES, NEC [7389]
IRS NUMBER: 271605762
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1130
BUSINESS ADDRESS:
STREET 1: 44111 NOBEL DRIVE
CITY: FREMONT
STATE: CA
ZIP: 94538
BUSINESS PHONE: 1-510-565-3178
MAIL ADDRESS:
STREET 1: 44111 NOBEL DRIVE
CITY: FREMONT
STATE: CA
ZIP: 94538
4
1
wf-form4_163597746107272.xml
FORM 4
X0306
4
2021-11-01
0
0001803599
Concentrix Corp
CNXC
0001270710
POLK DENNIS
44201 NOBEL DRIVE
FREMONT
CA
94538
1
0
0
0
Common Stock
2021-11-01
4
M
0
5000
37.94
A
32532
D
Common Stock
2021-11-01
4
S
0
200
173.84
D
32332
D
Common Stock
2021-11-01
4
S
0
400
175.09
D
31932
D
Common Stock
2021-11-01
4
S
0
700
175.697
D
31232
D
Common Stock
2021-11-01
4
S
0
2222
177.786
D
29010
D
Common Stock
2021-11-01
4
S
0
183
178.254
D
28827
D
Common Stock
2021-11-01
4
S
0
1295
179.663
D
27532
D
Employee Stock Option (Right to Buy)
37.94
2021-11-01
4
M
0
5000
0
D
2028-10-11
Common Stock
5000.0
57101
D
This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 19, 2021.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $173.41 to $174.29, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $174.56 to $175.52, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $175.56 to $175.98, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $177.22 to $178.21, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $178.24 to $178.26, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $179.37 to $180.155, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The stock option vested as to 20% of the shares on October 11, 2019, the first anniversary of the date of grant, and vests as to 1/60th of the shares monthly thereafter.
/s/ Andrew A. Farwig, Attorney-in-Fact
2021-11-03